These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 1116369

  • 1. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL, Bariso CD, Yuliano E, Hume RJ, Pasquale SA.
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [Abstract] [Full Text] [Related]

  • 2. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS.
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [Abstract] [Full Text] [Related]

  • 3. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 4. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis.
    Nuttall ID, Elstein M, Fahmy DR.
    Contraception; 1982 May; 25(5):463-9. PubMed ID: 6809424
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA, Brenner PF, Kletzky OA, Mishell DR.
    Am J Obstet Gynecol; 1978 Apr 01; 130(7):817-21. PubMed ID: 345817
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Apr 01; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 8. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 01; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 9. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 10. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA, Demers LM, Applebaum-Bowden D, Lenker R.
    Contraception; 1991 Aug 01; 44(2):113-24. PubMed ID: 1893706
    [Abstract] [Full Text] [Related]

  • 11. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
    Spona J, Feichtinger W, Kindermann C, Moore C, Mellinger U, Walter F, Gräser T.
    Contraception; 1997 Sep 01; 56(3):185-91. PubMed ID: 9347211
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ, Kletzky OA, Brenner PF, Mishell DR.
    Fertil Steril; 1978 Aug 01; 30(2):141-5. PubMed ID: 98356
    [Abstract] [Full Text] [Related]

  • 13. The mechanism of action of a new low-dosed combined oral contraceptive.
    Dericks-Tan JS, Schneider K, Taubert HD.
    Arch Gynecol; 1980 Aug 01; 229(2):107-14. PubMed ID: 6768343
    [Abstract] [Full Text] [Related]

  • 14. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
    Rahman SA, Jha P, Laumas V, Jain AK, Dileepkumar, Takkar D, Hingorani V, Laumas KR.
    Contraception; 1977 Nov 01; 16(5):487-97. PubMed ID: 590011
    [Abstract] [Full Text] [Related]

  • 15. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR, Kletzky OA, Brenner PF, Roy S, Nicoloff J.
    Am J Obstet Gynecol; 1977 May 01; 128(1):60-74. PubMed ID: 403765
    [Abstract] [Full Text] [Related]

  • 16. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul 01; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 17. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL, Katz M.
    Contraception; 1979 Nov 01; 20(5):475-87. PubMed ID: 393456
    [Abstract] [Full Text] [Related]

  • 18. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
    Ling WY, Johnston DW, Lea RH, Bent AE, Scott JZ, Toews MR.
    Contraception; 1985 Oct 01; 32(4):367-75. PubMed ID: 3935373
    [Abstract] [Full Text] [Related]

  • 19. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS, Chapdelaine A, Upmalis D, Olson W, Smith J.
    Acta Obstet Gynecol Scand Suppl; 1992 Oct 01; 156():9-14. PubMed ID: 1324557
    [Abstract] [Full Text] [Related]

  • 20. Clinical investigation of the biological effects of a new combination low-dose oral contraceptive ('Ovostat E').
    Tarkkila T, Hulkko S, Alapiessa U, Kauraniemi T.
    Curr Med Res Opin; 1977 Oct 01; 5(3):247-51. PubMed ID: 162661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.